Search

everythinglearnresearchcommunity

for

Search:↓

A new skin disease in four Labrador retrievers responded well to immunosuppressive treatment.

The rash resolved after stopping ponatinib.

Older men with scalp wounds had long-term healing problems after using imiquimod or diclofenac for skin cancer prevention.

Different techniques for vitiligo treatment work similarly well, with some better for specific body areas.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

Transplanting chest hair into scars can effectively treat wide donor scars from hair restoration surgery.

Transplanting beard hair into a scalp wound after hair transplant surgery improves scar appearance and hair keeps its normal traits.

Repeated biopsies are crucial for managing lupus panniculitis when initial treatments fail.

Renal transplant patients on tacrolimus and sirolimus may develop acne keloidalis nuchae.

CO₂ laser therapy improves skin and hair growth in localized scleroderma without severe side effects.

Skin problems can indicate different diseases inside the body.

A woman developed skin lesions after PRP injections, possibly linked to COVID-19 infection and vaccination.

Sintilimab treatment caused hair loss but led to complete tumor remission.

Triamcinolone acetonide helps scalp grafts grow hair successfully.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Noncultured epidermal cell transplantation is effective for repigmenting stable vitiligo.

Granulocyte colony stimulating factor helps heal wounds without scars.

Topical cyclosporin promotes hair growth.

A skin condition called pyodermatitis vegetans was found in a patient with multiple myeloma for the first time.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Tofacitinib effectively regrows hair in alopecia universalis triggered by a virus.

Ovarian function was similar in both treatment groups, but both caused excessive hair growth.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Psoriasis or contact dermatitis can override alopecia areata, allowing hair growth.

SLE patients experience hair loss similar to telogen effluvium, with hair damage and immune activity at hair follicles.

Two patients with lupus had an unusual type of hair loss not typical for the disease but improved with treatment.

Most HIV patients develop skin symptoms that can indicate the stage of their disease.